Our pipeline
We have an exciting and balanced pipeline underpinned by great science.
Use a maximum of two downloads here
Home / Our therapy areas / Our pipeline
[#top]
Latest quarterly updates
Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development.
197
projects in our pipeline
125
new molecular entities or major life-cycle management in Phase II or Phase III
20
new molecular entities in our late-stage pipeline
4
new molecular entities under review
Includes NME and major life-cycle management projects up to launch in applicable major markets.
[#oncology]
Click to edit therapy area details for dataName: Oncology
[#cvrm]
Click to edit therapy area details for dataName: Cardiovascular and Metabolic disease
[#respiratory]
Click to edit therapy area details for dataName: Respiratory
[#raredisease]
Click to edit therapy area details for dataName: Rare Disease
[#vi]
Click to edit therapy area details for dataName: Vaccine and Immune therapies
[#other]
Click to edit therapy area details for dataName: Other